JPRN-UMIN000021514招募中未知
PRECIOUS trial - PRECIOUS trial
Aichi cancer center hospital0 个研究点目标入组 370 人开始时间: 2016年3月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive StrategyPER-025-10sanofi-aventis Recherche & Development,50
撤回
不适用
CINCOR* TrialContrast-induced nephropathydisease of the kidneys1001108210029149NL-OMON34043Osprey Medical Inc.25
尚未招募
不适用
A study to evaluate the safety of immune cell therapy in early transplant period of hematopoietic stem cell transplant recipientsKCT0004024The Catholic University of Korea, Seoul St. Mary's Hospital32
进行中（未招募）
不适用
Full title of the trial : An open-label, multicentre, dose-escalating phase I/II trial of 3-weekly rhuMAb 2H7 in patients with follicular non Hodgkin’s lymphoma - N/Afollicular non-Hodgkin’s lymphoma (NHL)EUCTR2004-004110-17-SERoche Products Limited45
已完成
不适用
POINTER trial: postponed or immediate drainage of infected necrotizing pancreatitisGeïnfecteerde necrotiserende pancreatitisAcute necrotizing pancreatitis10017969severe acute pancreatitisNL-OMON47739Academisch Medisch Centrum104